title: Tranexamic acid-bevacizumab synergy in HHT patients presenting pulmonary arteriovenous malformations.
abstract: Bevacizumab and tranexamic acid have shown efficacy in the treatment of epistaxis and liver involvement of HHT patients. We suggest therapeutic association of bevacizumab and tranexamic acid should be further evaluated for the prevention and treatment of early lung involvement in HHT.
authors.affiliation: Centre d'imagerie Médicale, 47, Boulevard du Pont Rouge, 15000 Aurillac, France. lacout.alexis@wanadoo.fr
authors.forename: Alexis
authors.initials: A
authors.lastname: Lacout
authors.forename: Pierre Yves
authors.initials: PY
authors.lastname: Marcy
authors.forename: Mostafa
authors.initials: M
authors.lastname: El Hajjam
authors.forename: Pascal
authors.initials: P
authors.lastname: Lacombe
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D001165:Arteriovenous Malformations / Q000150:complications*; D000068258:Bevacizumab; D004357:Drug Synergism; D006801:Humans; D013683:Telangiectasia, Hereditary Hemorrhagic / Q000150:complications / Q000188:drug therapy*; D014148:Tranexamic Acid / Q000627:therapeutic use*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D014148:Tranexamic Acid